Advertisement Perrigo receives approval for acid reducer - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Perrigo receives approval for acid reducer

Perrigo has received final approval from the FDA for its abbreviated new drug application for over-the-counter famotidine 10mg, calcium carbonate 800mg, and magnesium hydroxide 165mg, chewable tablets.

The product will be marketed under store brand labels and is comparable to Johnson & Johnson – Merck Consumer Pharmaceutical’s Pepcid Complete, an acid reducer plus antacid medication indicated for the relief of heartburn associated with acid indigestion and sour stomach. The company expects to begin shipping the product in the third quarter of calendar 2008.